{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/658e4b085b1cd50016929a67/65d378a66dee7f0017c087ec?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Episode 1! Off to Tandem 24","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/658e4b085b1cd50016929a67/1708383396029-c8f3a6f7cf8b8839806df6fcb4eddb24.jpeg?height=200","description":"<p>Welcome! This is the first episode of Chimerically Speaking. We're excited to share our love for the science and brilliant, creative community of transplantation and cellular therapy. </p><p><br></p><p>In this episode we'll talk about the upcoming Tandem 2024 meeting ahead of traveling to San Antonio this week. We highlight two abstracts (of so many!) that really caught our attention:</p><p><br></p><p>Al Malki and colleages, TSC-100/TSC-101 Ph. 1 https://tandem.confex.com/tandem/2024/meetingapp.cgi/Paper/23846</p><p><br></p><p>Schoettler and colleagues, TA-TMA and age https://tandem.confex.com/tandem/2024/meetingapp.cgi/Paper/22981</p>","author_name":"Mohammad Alhomoud and Joshua Fein"}